Chipee, this time the risk of losing out is high if swing sell too soon. Might be a re rating soon for glove sector, which we see much earlier. But most likely take profit as the market will test the next resistance for at least twice , however looking at the bullish trend, might just only swing some profit. Trump will most likely increase taxes across the board for all imports and we have to scan the news especially the American glove manufacturers association. Good luck

Next Resistance level 2.51/2.52. Your call to be greedy or swing trade(some) . Still a longer term hold.

Wait until the actual account hit the streets. How much were thrown into the receivables and if the projected sales order are true.

Will wait at low 0.4 ex interlier founder family sold out. Now ex interlier known for operation excellent to helm the sinking ship

I think big funds will sideline until the US election

Sideways trading last 10 days. Strong price action yesterday afternoon. Let's see if can continue to break out strongly 2.1

market spook by Topglove operating loss again. Just look at the revenue increase as a benchmark and not be too concern as Kossan operating expenses is well control. The best amoung the top 4.

Thank you for the information and objectivity. Next 2 qtrs will have to be great if all the finincials estimates are accurate

Issue with India restriction on chlorinated latex glove, impacting mainly Harta.

Old story brought up b4 covid. Polymer coated or chlorinated rubber gloves meets Fda regulation to prevent allergy. Will be knee jerk reaction. Only India decide to buy the more expensive polymer coated gloves because they care about the environment 😂

Kenanga finally throw in the towel! Overweight on gloves finally. 😀

Ustr is a 4 Yr review cycle but one analyst mentioned 2 and down play the news. I suspect Trump to win and seal this until end 2028. China will not be able to continue to subsidize glove industry and retarget their focus. ASP will continue to rise and allow US manufacturers to start production, by then Malaysian glove industry will have a windfall in the next 4 yrs years at least. Let's see how is the profit taking today and see how foreign funds read the news.

Looking at EU and Canada tariffs on China ev and I am sure other industry will follow the precedent set by US administration. They always follow the big brother. Will scout around for the news.

I suspect this will not be a one day show. Will not swing too soon as the momentum is just right with feds interest rates decision on wed. The closing few hours volume continue to come in. Good luck for tmrow.

Happy to share good news :) let's see how the market reacts. Will take a few days for analysts to absorb

Chipee here is the link https://ustr.gov/sites/default/files/05.14.2024%20Four%20Year%20Review%20of%20China%20Tech%20Transfer%20Section%20301%20(Final).pdf

https://ustr.gov/sites/default/files/05.14.2024%20Four%20Year%20Review%20of%20China%20Tech%20Transfer%20Section%20301%20(Final).pdf

Considering the public comments, the specific direction of the President to increase
tariffs on medical gloves no less than 25 percent in 2026, and the advice of the Section 301
Committee, particularly agencies involved in U.S. medical preparedness, the U.S. Trade
Representative has determined to increase the rate of additional duties on medical gloves to
50 percent in 2025 and to 100 percent in 2026
From ustr website. Pls verify

shorts having a field day, such a good qtrly , short down till 2.45 support level.

Ops expenses reduce 430k to 409k. Trade receivable flat qtq but 30k higher than 2023. Red Sea is not really a big problem. Most expect better revenue. Best operating margin, well manage but can they manage the sales volume. If flat again next quarter, time to reasses. USTR should have a statement end of the week or next week

@patron the final ustr 301 determination has been delayed until the end of August. They are negotiating and getting feedback, one of the proposal is a 50 percent in medical ppe in 2025 while relaxing critical syringes tariffs. This is based after feedback from both medical associations and manufactures associations. Let's see how. Will scout around and published as soon as I can.

Have to hold longer, no concern next few qtrs, just no easy money, unless ustr pull in the tariffs to 2025. Or set it to 50 percent as propose

Qtr high change out today afternoon. Looking for 2x increase in earnings q2q.

Can the earnings double from previous qtr and push down the pe to below 40? This should preview kossan potential.

Covid vaccination glove is recommended Mpox is a requirement. Covid has shown global increase in outpatient care and new vaccine to be push to public in autumn /Oct. Let's see the market reaction. Quarterly results will pull in the crowd but dramatic news will ignite the rush to health care stocks.

https://www.cnbc.com/2024/08/15/mpox-health-stocks-jump-as-who-declares-global-health-emergency.html

https://www.bloomberg.com/news/articles/2024-08-13/covid-linked-stocks-are-back-in-play-as-asia-sees-surge-in-cases?utm_source=website&utm_medium=share&utm_campaign=copy

https://www.ammaunited.org/2024/amma-to-ustr-we-can-do-more/. America medical manufacturer association proposal to ustr in July 3. End of July Ustr request feedback if increasing up to 50 percent on ppe etc is acceptable. AMMA is proposing to bring it forward to allow better playing field for US manufacturers. Supermax will be the main beneficiary but all counters will benefit if Congress approve this.

EPF is buying again. The market markers are shaking the weak holders. I am disappointed as miss this swing. Did not expect to go so low. Expect qtrly to trigger more buy support and hopefully good news from Ustr final review by mid August. Else longer wait

They might increase the tariff to 50 percent as medical industry provide positive comment on alternative supplier

https://www.reuters.com/world/us-says-start-new-china-tariffs-will-be-delayed-by-least-two-weeks-2024-07-30/

BTW the factories planner still very busy with the ramp up. And August ustr tariff will consolidate the industry feedback. If they will increase/reduce /stick to 25 percent tariff. I have read the summary medical gloves are considered no risk as alternative is easily available. So they might even increase and reduce trade items that has difficulty in their supply chain.

Demand is going strong. IB decided to take profit earlier than expected. Fundamentals has not changed. IB has insider advantage on what they will post and shorties will be glad to support. Have to wait another round when they need to cover their shorts. Already stable in the afternoon. Many caught off guard this time

Quad witching hour this friday. Trade with care, expect high volume surge and violatility due to options expiry.

Cup and handle forming, high chance for a breakout next week to test recent high. The cup depth is small and handle volume is small as well. Let's see how, good luck

Chipee thanks for the information. We know each quarter results will be better than the last for at least end of the year and next year US will start transition their supplier away from China.

Great insight. Need confirmation of their operation efficiency and with utilzation improving to above 80%. KOSSAN should surpass Harta soon.

Money is coming back in to klse. Better sharpen your technicals. Fundamentals will take a back seat, swing it well and good luck

The US Cpe inflation is within expectation and Ecb most likely to cut rate in June. Tuesday will be a good time to bottom pick. Good luck

ECB will reduce interest rate. Europe base funds might come in in anticipation of Euro going down. However US CPE data might be prove to be resilient and make US jittery again. Next week will be better to decide.

No concern on the glove fundamentals. Better to wait for a clear uptrend tmrow or fri

Can start to pick the bottom, tmrow or better Friday

Buy lah sell later

With the rate on how well KOSSAN managed it's operating expenses vs Harta(ops expenses more than revenue due to decommissioning old to new plants), I won't be surprised KOSSAN market cap to surpass Harta by year end. Good luck, better reposition your glove portfolio

HARTA declare operating expenses is higher due material, gas and other operating costs. Infact increase from yoy. Yet KOSSAN is able to ramp up with lower operating cost with less revenue increase. Hopefully is due to decision to set up new lines that has yet to be utilised in the Bestari line

Support is still very strong . Strong closing candle for harta. Flag pole and pendant pattern forming. High chance to continue the upward momentum in the near term. Simlar pattern seen for Kossan . Hopefully Kossan qtrly will satisfy the market with qtq increase in revenue and profit.

Ok lah, recovery will be there . Fluctuation is as expected, it cost money to ramp up the lines...important sales are back

QTRLY should be out this week by Friday. Today might be possible due to wesak tmrow. Hope to see another round of interest.

This new flirt variant is so far the most virulent since it became endemic. 25k cases and doubled every week in Singapore as community immunity has dwindled.

The flirt variant is hitting US as well.